LEXAURUM ADVISORS, LLC – Eli Lilly and Company Transaction History
LEXAURUM ADVISORS, LLC portfolio value:
$452,000
portfolio value
LEXAURUM ADVISORS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.50% | -7 shares | -4K | $323.35 | 1.39K |
| Q2 2022 | share | Decrease | -13.85% | -226 shares | -11K | $324.23 | 1.40K |
| Q1 2022 | share | Decrease | -0.12% | -2 shares | 16K | $286.37 | 1.63K |
| Q4 2021 | share | Decrease | -4.56% | -78 shares | 55K | $277.25 | 1.63K |
| Q3 2021 | share | 0.00% | 0 shares | 3K | $230.3 | 1.71K | |
| Q2 2021 | share | 0.00% | 0 shares | 73K | $228.04 | 1.71K | |
| Q1 2021 | share | Decrease | -15.71% | -319 shares | -23K | $184.81 | 1.71K |
| Q4 2020 | share | 0.00% | 0 shares | 42K | $166.32 | 2.03K | |
| Q3 2020 | share | Decrease | -1.60% | -33 shares | -38K | $145.05 | 2.03K |
| Q2 2020 | share | Decrease | -5.75% | -126 shares | 35K | $160.1 | 2.06K |
| Q1 2020 | share | 0.00% | 0 shares | 16K | $134.64 | 2.19K | |
| Q4 2019 | share | 0.00% | 0 shares | 43K | $126.91 | 2.19K | |
| Q3 2019 | share | 0.00% | 0 shares | 2K | $107.36 | 2.19K | |
| Q2 2019 | share | Decrease | -0.27% | -6 shares | -42K | $105.74 | 2.19K |
| Q1 2019 | share | 0.00% | 0 shares | 31K | $123.17 | 2.19K | |
| Q4 2018 | share | Increase | +5.63% | 117 shares | 31K | $109.26 | 2.19K |
| Q3 2018 | share | Increase | 0.00% | 2.07K shares | 223K | $100.8 | 2.07K |
| Q1 2018 | share | Decrease | -100.00% | -2.65K shares | -231K | $71.78 | 0 |
| Q4 2017 | share | Increase | 0.00% | 2.65K shares | 231K | $77.79 | 2.65K |